Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 24Terminated 6Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 4Thoracic 1Plasma cell 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Lymphoma 3Mycosis Fungoides 2Sezary Syndrome 1Parapsoriasis 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Interventional × Bexarotene × Clear all
NCT00615784 2020-12-17

UPCC04407

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
24 enrolled 4 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00153842 2019-03-06

A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase 1/2 Terminated
33 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

NCT01504490 2017-02-14

Phase I Study of CS-7017 and Bexarotene

Georgetown University

Phase 1 Terminated
9 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT00127101 2015-04-21

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Merck Sharp & Dohme LLC

Phase 1 Terminated
23 enrolled 13 charts
Lymphoid

Lymphoma

NCT00322296 2013-04-16

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Fox Chase Cancer Center

Phase 2 Terminated
8 enrolled
DermatologicLymphoid

Mycosis Fungoides, Parapsoriasis, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡